Enforcement Report - Week Of June 01, 2022
Enforcement Report - Week of March 30, 2022
Enforcement Report - Week of November 17, 2021
Innoveix Pharmaceuticals Issues Voluntary Recall of all Sterile Compounded Drug Products
KRS Global Biotechnology Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products
Enforcement Report - Week of June 19, 2019
U.S. District Judge Keith P. Ellison for the Southern District of Texas signed and entered a consent decree of permanent injunction, ordering a Texas-based company and its owners to stop producing compounded drugs intended to be sterile until the company complies with the Federal Food, Drug, and Cosmetic Act (FD&C Act) and other requirements. According to the complaint, despite previous warnings from the U.S. Food and Drug Administration, Pharm D Solutions, LLC, as well as the company’s owners, Luis R. De Leon and Juan C. De Leon, continued to violate the law, putting patients at risk.
Enforcement Report - Week of April 24, 2019
FDA alerts Not to use Promise Pharmacy`s drugs intended to be sterile
Enforcement Report - Week of November 7, 2018